Circulating microRNAs as specific biomarkers for breast cancer detection.

<h4>Background</h4>We previously showed microRNAs (miRNAs) in plasma are potential biomarkers for colorectal cancer detection. Here, we aimed to develop specific blood-based miRNA assay for breast cancer detection.<h4>Methodology/principal findings</h4>TaqMan-based miRNA prof...

Full description

Saved in:
Bibliographic Details
Main Authors: Enders K O Ng, Rufina Li, Vivian Y Shin, Hong Chuan Jin, Candy P H Leung, Edmond S K Ma, Roberta Pang, Daniel Chua, Kent-Man Chu, W L Law, Simon Y K Law, Ronnie T P Poon, Ava Kwong
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0053141&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849330060378505216
author Enders K O Ng
Enders K O Ng
Rufina Li
Vivian Y Shin
Hong Chuan Jin
Candy P H Leung
Edmond S K Ma
Roberta Pang
Daniel Chua
Kent-Man Chu
W L Law
Simon Y K Law
Ronnie T P Poon
Ava Kwong
author_facet Enders K O Ng
Enders K O Ng
Rufina Li
Vivian Y Shin
Hong Chuan Jin
Candy P H Leung
Edmond S K Ma
Roberta Pang
Daniel Chua
Kent-Man Chu
W L Law
Simon Y K Law
Ronnie T P Poon
Ava Kwong
author_sort Enders K O Ng
collection DOAJ
description <h4>Background</h4>We previously showed microRNAs (miRNAs) in plasma are potential biomarkers for colorectal cancer detection. Here, we aimed to develop specific blood-based miRNA assay for breast cancer detection.<h4>Methodology/principal findings</h4>TaqMan-based miRNA profiling was performed in tumor, adjacent non-tumor, corresponding plasma from breast cancer patients, and plasma from matched healthy controls. All putative markers identified were verified in a training set of breast cancer patients. Selected markers were validated in a case-control cohort of 170 breast cancer patients, 100 controls, and 95 other types of cancers and then blindly validated in an independent set of 70 breast cancer patients and 50 healthy controls. Profiling results showed 8 miRNAs were concordantly up-regulated and 1 miRNA was concordantly down-regulated in both plasma and tumor tissue of breast cancer patients. Of the 8 up-regulated miRNAs, only 3 were significantly elevated (p<0.0001) before surgery and reduced after surgery in the training set. Results from the validation cohort showed that a combination of miR-145 and miR-451 was the best biomarker (p<0.0001) in discriminating breast cancer from healthy controls and all other types of cancers. In the blind validation, these plasma markers yielded Receiver Operating Characteristic (ROC) curve area of 0.931. The positive predictive value was 88% and the negative predictive value was 92%. Altered levels of these miRNAs in plasma have been detected not only in advanced stages but also early stages of tumors. The positive predictive value for ductal carcinoma in situ (DCIS) cases was 96%.<h4>Conclusions</h4>These results suggested that these circulating miRNAs could be a potential specific biomarker for breast cancer screening.
format Article
id doaj-art-3c87d7ece03e488f909bf810f0b4c798
institution Kabale University
issn 1932-6203
language English
publishDate 2013-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-3c87d7ece03e488f909bf810f0b4c7982025-08-20T03:47:05ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0181e5314110.1371/journal.pone.0053141Circulating microRNAs as specific biomarkers for breast cancer detection.Enders K O NgEnders K O NgRufina LiVivian Y ShinHong Chuan JinCandy P H LeungEdmond S K MaRoberta PangDaniel ChuaKent-Man ChuW L LawSimon Y K LawRonnie T P PoonAva Kwong<h4>Background</h4>We previously showed microRNAs (miRNAs) in plasma are potential biomarkers for colorectal cancer detection. Here, we aimed to develop specific blood-based miRNA assay for breast cancer detection.<h4>Methodology/principal findings</h4>TaqMan-based miRNA profiling was performed in tumor, adjacent non-tumor, corresponding plasma from breast cancer patients, and plasma from matched healthy controls. All putative markers identified were verified in a training set of breast cancer patients. Selected markers were validated in a case-control cohort of 170 breast cancer patients, 100 controls, and 95 other types of cancers and then blindly validated in an independent set of 70 breast cancer patients and 50 healthy controls. Profiling results showed 8 miRNAs were concordantly up-regulated and 1 miRNA was concordantly down-regulated in both plasma and tumor tissue of breast cancer patients. Of the 8 up-regulated miRNAs, only 3 were significantly elevated (p<0.0001) before surgery and reduced after surgery in the training set. Results from the validation cohort showed that a combination of miR-145 and miR-451 was the best biomarker (p<0.0001) in discriminating breast cancer from healthy controls and all other types of cancers. In the blind validation, these plasma markers yielded Receiver Operating Characteristic (ROC) curve area of 0.931. The positive predictive value was 88% and the negative predictive value was 92%. Altered levels of these miRNAs in plasma have been detected not only in advanced stages but also early stages of tumors. The positive predictive value for ductal carcinoma in situ (DCIS) cases was 96%.<h4>Conclusions</h4>These results suggested that these circulating miRNAs could be a potential specific biomarker for breast cancer screening.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0053141&type=printable
spellingShingle Enders K O Ng
Enders K O Ng
Rufina Li
Vivian Y Shin
Hong Chuan Jin
Candy P H Leung
Edmond S K Ma
Roberta Pang
Daniel Chua
Kent-Man Chu
W L Law
Simon Y K Law
Ronnie T P Poon
Ava Kwong
Circulating microRNAs as specific biomarkers for breast cancer detection.
PLoS ONE
title Circulating microRNAs as specific biomarkers for breast cancer detection.
title_full Circulating microRNAs as specific biomarkers for breast cancer detection.
title_fullStr Circulating microRNAs as specific biomarkers for breast cancer detection.
title_full_unstemmed Circulating microRNAs as specific biomarkers for breast cancer detection.
title_short Circulating microRNAs as specific biomarkers for breast cancer detection.
title_sort circulating micrornas as specific biomarkers for breast cancer detection
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0053141&type=printable
work_keys_str_mv AT enderskong circulatingmicrornasasspecificbiomarkersforbreastcancerdetection
AT enderskong circulatingmicrornasasspecificbiomarkersforbreastcancerdetection
AT rufinali circulatingmicrornasasspecificbiomarkersforbreastcancerdetection
AT vivianyshin circulatingmicrornasasspecificbiomarkersforbreastcancerdetection
AT hongchuanjin circulatingmicrornasasspecificbiomarkersforbreastcancerdetection
AT candyphleung circulatingmicrornasasspecificbiomarkersforbreastcancerdetection
AT edmondskma circulatingmicrornasasspecificbiomarkersforbreastcancerdetection
AT robertapang circulatingmicrornasasspecificbiomarkersforbreastcancerdetection
AT danielchua circulatingmicrornasasspecificbiomarkersforbreastcancerdetection
AT kentmanchu circulatingmicrornasasspecificbiomarkersforbreastcancerdetection
AT wllaw circulatingmicrornasasspecificbiomarkersforbreastcancerdetection
AT simonyklaw circulatingmicrornasasspecificbiomarkersforbreastcancerdetection
AT ronnietppoon circulatingmicrornasasspecificbiomarkersforbreastcancerdetection
AT avakwong circulatingmicrornasasspecificbiomarkersforbreastcancerdetection